The essential role of transient receptor potential vanilloid 1 in simvastatin-induced activation of endothelial nitric oxide synthase and angiogenesis

Acta Physiologica

Volumn 212, Issue 3, 2014, Pages 191-204

  Su, K H ^a   Lin, S J ^b   Wei, J ^c   Lee, K I ^a   Zhao, J F ^a   Shyue, S K ^d   Lee, T S ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Angiogenesis; Ca2+; eNOS; Simvastatin; TRPV1 channels

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, MOUSE; PROTEIN KINASE B; SIMVASTATIN; TRPV1 PROTEIN, MOUSE; VANILLOID RECEPTOR;

ANIMAL; C57BL MOUSE; ENDOTHELIUM CELL; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; ENDOTHELIAL CELLS; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SIMVASTATIN; TRPV CATION CHANNELS;

EID: 84907962819     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12378     Document Type: Article

References (40)

1. Ahmmed, G.U. & Malik, A.B. 2005. Functional role of TRPC channels in the regulation of endothelial permeability. Pflugers Arch 451, 131-142.
2. Arnould, T., Michiels, C., Alexandre, I. & Remacle, J. 1992. Effect of hypoxia upon intracellular calcium concentration of human endothelial cells. J Cell Physiol 152, 215-221.
3. Balzer, M., Lintschinger, B. & Groschner, K. 1999. Evidence for a role of Trp proteins in the oxidative stress-induced membrane conductances of porcine aortic endothelial cells. Cardiovasc Res 42, 543-549.
4. Bauersachs, J., Hiss, K., Fraccarollo, D., Laufs, U. & Ruetten, H. 2006. Simvastatin improves left ventricular function after myocardial infarction in hypercholesterolemic rabbits by anti-inflammatory effects. Cardiovasc Res 72, 438-446.
5. Baylie, R.L. & Brayden, J.E. 2011. TRPV channels and vascular function. Acta Physiol (Oxf) 203, 99-116.
6. Bodkin, J.V. & Brain, S.D. 2011. Transient receptor potential ankyrin 1: emerging pharmacology and indications for cardiovascular biology. Acta Physiol (Oxf) 203, 87-98.
7. Brayden, J.E., Earley, S., Nelson, M.T. & Reading, S. 2008. Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow. Clin Exp Pharmacol Physiol 35, 1116-1120.
8. Ching, L.C., Kou, Y.R., Shyue, S.K., Su, K.H., Wei, J., Cheng, L.C., Yu, Y.B., Pan, C.C. & Lee, T.S. 2011. Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc Res 91, 492-501.
9. Ching, L.C., Chen, C.Y., Su, K.H., Hou, H.H., Shyue, S.K., Kou, Y.R. & Lee, T.S. 2012. Implication of AMP-activated protein kinase in transient receptor potential vanilloid type 1-mediated activation of endothelial nitric oxide synthase. Mol Med 18, 805-815.
10. Ching, L.C., Zhao, J.F., Su, K.H., Shyue, S.K., Hsu, C.P., Lu, T.M., Lin, S.J. & Lee, T.S. 2013. Activation of transient receptor potential vanilloid 1 decreases endothelial nitric oxide synthase phosphorylation at Thr497 by protein phosphatase 2B-dependent dephosphorylation of protein kinase C. Acta Physiol (Oxf) 209, 124-135.
11. 2+ signals and nitric oxide synthesis through epidermal growth factor receptor kinase and calmodulin kinase II. J Biol Chem 280, 35999-36006.
12. Di Napoli, P., Antonio Taccardi, A., Grilli, A., Spina, R., Felaco, M., Barsotti, A. & De Caterina, R. 2001. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts. Cardiovasc Res 51, 283-293.
13. Dietrich, A., Kalwa, H. & Gudermann, T. 2010. TRPC channels in vascular cell function. Thromb Haemost 103, 262-270.
14. Feron, O., Dessy, C., Desager, J.P. & Balligand, J.L. 2001. Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation 103, 113-118.
15. Gazzieri, D., Trevisani, M., Tarantini, F., Bechi, P., Masotti, G., Gensini, G.F., Castellani, S., Marchionni, N., Geppetti, P. & Harrison, S. 2006. Ethanol dilates coronary arteries and increases coronary flow via transient receptor potential vanilloid 1 and calcitonin gene-related peptide. Cardiovasc Res 70, 589-599.
16. Hellwig, N., Albrecht, N., Harteneck, C., Schultz, G. & Schaefer, M. 2005. Homo- and heteromeric assembly of TRPV channel subunits. J Cell Sci 118, 917-928.
17. Kassmann, M., Harteneck, C., Zhu, Z., Nürnberg, B., Tepel, M. & Gollasch, M. 2013. Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney. Acta Physiol (Oxf) 207, 546-564.
18. Kawasaki, H., Takatori, S., Zamami, Y., Koyama, T., Goda, M., Hirai, K., Tangsucharit, P., Jin, X., Hobara, N. & Kitamura, Y. 2011. Paracrine control of mesenteric perivascular axo-axonal interaction. Acta Physiol (Oxf) 203, 3-11.
19. Kone, B.C. 2000. Protein-protein interactions controlling nitric oxide synthases. Acta Physiol Scand 168, 27-31.
20. Kou, R., Sartoretto, J. & Michel, T. 2009. Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-β. J Biol Chem 284, 14734-14743.
21. 2+ inhibits murine keratinocyte differentiation in vitro. J Cell Physiol 163, 105-114.
22. Ma, L., Zhong, J., Zhao, Z., Luo, Z., Ma, S., Sun, J., He, H., Zhu, T., Liu, D., Zhu, Z. & Tepel, M. 2011. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. Cardiovasc Res 92, 504-513.
23. Mohapatra, D.P., Wang, S.Y., Wang, G.K. & Nau, C. 2003. A tyrosine residue in TM6 of the vanilloid receptor TRPV1 involved in desensitization and calcium permeability of capsaicin-activated currents. Mol Cell Neurosci 23, 314-324.
24. Mölgaard, J., von Schenck, H. & Olsson, A.G. 1988. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia. Eur Heart J 9, 541-551.
25. Mori, Y., Kajimoto, T., Nakao, A., Takahashi, N. & Kiyonaka, S. 2011. Receptor signaling integration by TRP channelsomes. Adv Exp Med Biol 704, 373-389.
26. 2+. Neuroscience 171, 1109-1119.
27. Pozsgai, G., Bodkin, J.V., Graepel, R., Bevan, S., Andersson, D.A. & Brain, S.D. 2010. Evidence for the pathophysiological relevance of TRPA1 receptors in the cardiovascular system in vivo. Cardiovasc Res 87, 760-768.
28. 2+ responses to noradrenaline: possible role of TRPC channels. Acta Physiol (Oxf) 200, 265-278.
29. 2+/calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 284, H2311-H2319.
30. Senadheera, S., Kim, Y., Grayson, T.H., Toemoe, S., Kochukov, M.Y., Abramowitz, J., Housley, G.D., Bertrand, R.L., Chadha, P.S., Bertrand, P.P., Murphy, T.V., Tare, M., Birnbaumer, L., Marrelli, S.P. & Sandow, S.L. 2012. Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity. Cardiovasc Res 95, 439-447.
31. Settergren, M., Böhm, F., Rydén, L. & Pernow, J. 2008. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. Eur Heart J 29, 1753-1760.
32. Su, K.H., Tsai, J.Y., Kou, Y.R., Chiang, A.N., Hsiao, S.H., Wu, Y.L., Hou, H.H., Pan, C.C., Shyue, S.K. & Lee, T.S. 2009. Valsartan regulates the interaction of angiotensin II type 1 receptor and endothelial nitric oxide synthase via Src/PI3K/Akt signalling. Cardiovasc Res 82, 468-475.
33. Su, K.H., Shyue, S.K., Kou, Y.R., Ching, L.C., Chiang, A.N., Yu, Y.B., Chen, C.Y., Pan, C.C. & Lee, T.S. 2011. β common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase. J Cell Physiol 226, 3330-3339.
34. Sun, W., Lee, T.S., Zhu, M., Gu, C., Wang, Y., Zhu, Y. & Shyy, J.Y. 2006. Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114, 2655-2662.
35. Venkatachalam, K. & Montell, C. 2007. TRP channels. Annu Rev Biochem 76, 387-417.
36. Wei, J., Ching, L.C., Zhao, J.F., Shyue, S.K., Lee, H.F., Kou, Y.R. & Lee, T.S. 2013. Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis. Acta Physiol (Oxf) 207, 299-307.
37. Wu, M., Komori, N., Qin, C., Farber, J.P., Linderoth, B. & Foreman, R.D. 2007. Roles of peripheral terminals of transient receptor potential vanilloid-1 containing sensory fibers in spinal cord stimulation-induced peripheral vasodilation. Brain Res 1156, 80-92.
38. Yang, D., Luo, Z., Ma, S., Wong, W.T., Ma, L., Zhong, J., He, H., Zhao, Z., Cao, T., Yan, Z., Liu, D., Arendshorst, W.J., Huang, Y., Tepel, M. & Zhu, Z. 2010. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 12, 130-141.
39. Zhao, J.F., Ching, L.C., Kou, Y.R., Lin, S.J., Wei, J., Shyue, S.K. & Lee, T.S. 2013. Activation of TRPV1 prevents oxLDL-induced lipid accumulation and TNF-α-induced inflammation in macrophages: role of liver X receptor α. Mediators Inflamm 2013, 925171.
40. Zhou, Y., Lewis, T.L., Robinson, L.J., Brundage, K.M., Schafer, R., Martin, K.H., Blair, H.C., Soboloff, J. & Barnett, J.B. 2011. The role of calcium release activated calcium channels in osteoclast differentiation. J Cell Physiol 226, 1082-1089.